Хайлтын үр дүнгүүд - Wechalekar, Ashutosh
- 55-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
-
4
-
5
-
6
Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of c... -н Wechalekar, Ashutosh D., Gillmore, Julian D., Wassef, Nancy, Lachmann, Helen J., Whelan, Carol, Hawkins, Philip N.
Хэвлэсэн 2011текст -
7
Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds -н Wagner, T., Page, J., Burniston, M., Skillen, A., Ross, J. C., Manwani, R., McCool, D., Hawkins, P. N., Wechalekar, Ashutosh D.
Хэвлэсэн 2018текст -
8
-
9
Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study -н Banypersad, Sanjay M, Fontana, Marianna, Maestrini, Viviana, Sado, Daniel, White, Steven K, Treibel, Thomas A, Lachmann, Helen, Wechalekar, Ashutosh, Hawkins, Philip N, Moon, James
Хэвлэсэн 2014текст -
10
Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen Aα-Chain Amyloidosis -н Gillmore, Julian D., Lachmann, Helen J., Rowczenio, Dorota, Gilbertson, Janet A., Zeng, Cai-Hong, Liu, Zhi-Hong, Li, Lei-Shi, Wechalekar, Ashutosh, Hawkins, Philip N.
Хэвлэсэн 2009текст -
11
A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis -н Sharpley, Faye A., Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Fontana, Marianna, Hawkins, Philip N., Wechalekar, Ashutosh D.
Хэвлэсэн 2019текст -
12
Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis -н Sachchithanantham, Sajitha, Offer, Mark, Venner, Christopher, Mahmood, Shameem A., Foard, Darren, Rannigan, Lisa, Lane, Thirusha, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.
Хэвлэсэн 2015текст -
13
Deferred autologous stem cell transplantation in systemic AL amyloidosis -н Manwani, Richa, Hegenbart, Ute, Mahmood, Shameem, Sachchithanantham, Sajitha, Kyriakou, Charalampia, Yong, Kwee, Popat, Rakesh, Rabin, Neil, Whelan, Carol, Dittrich, Tobias, Kimmich, Christoph, Hawkins, Philip, Schönland, Stefan, Wechalekar, Ashutosh
Хэвлэсэн 2018текст -
14
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria -н Sharpley, Faye A., Fontana, Marianna, Martinez-Naharro, Ana, Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Hawkins, Philip N., Wechalekar, Ashutosh D.
Хэвлэсэн 2020текст -
15
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID‐19 pandemic -н Kastritis, Efstathios, Wechalekar, Ashutosh, Schönland, Stefan, Sanchorawala, Vaishali, Merlini, Giampaolo, Palladini, Giovanni, Minnema, Monique, Roussel, Murielle, Jaccard, Arnaud, Hegenbart, Ute, Kumar, Shaji, Cibeira, Maria T., Blade, Joan, Dimopoulos, Meletios A.
Хэвлэсэн 2020текст -
16
Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis -н Ravichandran, Sriram, Law, Steven, Mahmood, Shameem, Wisniowski, Brenden, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.
Хэвлэсэн 2022текст -
17
Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis -н Dungu, Jason, Whelan, Carol J, Gibbs, Simon D, Pinney, Jennifer H, Banypersad, Sanjay M, Venner, Christopher P, Lachmann, Helen J, Wechalekar, Ashutosh, Gillmore, Julian D, Hawkins, Philip N, Anderson, Lisa
Хэвлэсэн 2012текст -
18
Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis -н Manwani, Richa, Foard, Darren, Mahmood, Shameem, Sachchithanantham, Sajitha, Lane, Thirusha, Quarta, Cristina, Youngstein, Taryn, Rezk, Tamer, Lachmann, Helen J, Gillmore, Julian D., Fontana, Marianna, Whelan, Carol, Hawkins, Philip N., Wechalekar, Ashutosh
Хэвлэсэн 2018текст -
19
Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib -н Ravichandran, Sriram, Cohen, Oliver C., Law, Steven, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Sachchithanantham, Sajitha, Mahmood, Shameem, Hawkins, Philip N., Wechalekar, Ashutosh D.
Хэвлэсэн 2021текст -
20
The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis -н Rezk, Tamer, Gilbertson, Janet A, Mangione, P Patrizia, Rowczenio, Dorota, Rendell, Nigel B, Canetti, Diana, Lachmann, Helen J, Wechalekar, Ashutosh D, Bass, Paul, Hawkins, Philip N, Bellotti, Vittorio, Taylor, Graham W, Gillmore, Julian D
Хэвлэсэн 2019текст